Energy and mental performance are increasingly viewed not as fixed traits but as biological systems that can be supported and optimized. Sleep, nutrition, and exercise remain the foundation — but for those who have those bases covered and are looking for additional leverage, a category of peptides has emerged that directly targets neurological function, cellular energy production, and stress resilience.
This stack is distinct from the others in the series in that it spans two domains: neurological performance (focus, clarity, stress response) and metabolic energy (cellular ATP production, mitochondrial efficiency). The peptides most commonly used here tend to come from neuroscience and molecular biology research rather than from sports medicine.
Semax
What it is: Semax is a synthetic heptapeptide (7 amino acids) derived from adrenocorticotropic hormone (ACTH), originally developed in Russia in the 1980s by the Institute of Molecular Genetics. It was developed for neuroprotective and cognitive applications and is still used clinically in Russia for stroke recovery, cognitive decline, and attention disorders.
How it works:
- Stimulates the release of Brain-Derived Neurotrophic Factor (BDNF) — a protein critical to the growth, maintenance, and plasticity of neurons. BDNF is sometimes described as “fertilizer for the brain” because of its role in neurogenesis and synaptic strength
- Inhibits the breakdown of enkephalins, naturally occurring peptides that modulate pain, stress response, and mood
- Has dopaminergic and serotonergic activity, influencing mood, motivation, and focus
- Demonstrated neuroprotective effects in models of ischemia and oxidative stress
What users report: Semax is frequently described as producing a clean, sustained lift in mental clarity and focus — without the jitteriness or crash associated with stimulants. Users report improved cognitive endurance during demanding work, enhanced mood and motivation, and a general sense of mental sharpness. Some describe effects that linger beyond the period of active use, consistent with the BDNF mechanism (BDNF promotes lasting structural changes in the brain rather than just transient stimulation).
Administration: Intranasal (nasal spray) is the most common route. Oral bioavailability is poor due to enzymatic degradation. Some users use subcutaneous injection.
Typical dosing: 100–600 mcg intranasally, once or twice daily. Lower doses tend to be more activating; higher doses can have a more calming, anxiolytic quality for some users.
Approximate pricing: $30–$60 per nasal spray bottle (providing approximately 30 days of standard use).
Pricing shown reflects research vendor market rates as of publication. Physician-compounded versions through licensed pharmacies are priced differently and include clinical oversight, quality testing, and prescription fulfillment.
Regulatory update (2026): Semax and Selank are among the peptides expected to return to Category 1 compounding status following the February 2026 HHS announcement, which would restore legal access through licensed physicians and compounding pharmacies. BodyCircuit will update this article as formal FDA guidance is published.
Selank
What it is: Selank is a synthetic heptapeptide developed at the same Russian institute as Semax, derived from the immune peptide tuftsin. While Semax leans toward the stimulating and focus-enhancing end of the spectrum, Selank occupies the complementary position: anxiolytic (anxiety-reducing), mood-stabilizing, and gently cognitive-enhancing — without sedation.
How it works:
- Modulates GABA-A receptor activity, producing anxiolytic effects through the same broad receptor system as benzodiazepines — but through a different, non-habit-forming mechanism
- Stimulates BDNF expression, similar to Semax
- Modulates the serotonin and dopamine systems, supporting mood stability and emotional resilience
- Has immunomodulatory properties (relevant to the Immune Support stack as well)
- Shown to reduce anxiety and improve cognitive function in models of stress-induced impairment
What users report: Selank is consistently described as producing a calm, clear mental state — reduced anxiety without sedation, improved ability to focus under stress, and enhanced emotional stability. It’s often compared to very mild benzodiazepines in terms of anxiety relief but without the cognitive blunting or dependence concerns.
Many users pair Semax and Selank together, using one in the morning for focus and energy and the other as needed for stress and anxiety management. Some cycle them daily.
Administration: Intranasal nasal spray, same as Semax.
Typical dosing: 250–750 mcg intranasally, as needed or 1–2x daily.
Approximate pricing: $30–$60 per nasal spray bottle.
MOTS-c
What it is: MOTS-c is a mitochondrially derived peptide — meaning it’s encoded directly by mitochondrial DNA rather than the nuclear genome. It was identified relatively recently (2015) by researchers at the University of Southern California and has rapidly become one of the most interesting compounds in longevity and metabolic performance research.
How it works:
- Activates AMPK (AMP-activated protein kinase) — a master metabolic regulator that promotes fat oxidation, mitochondrial biogenesis, and cellular energy efficiency. AMPK is activated by exercise and caloric restriction; MOTS-c appears to mimic some of these benefits
- Improves insulin sensitivity and glucose uptake in muscle cells
- Enhances exercise performance and endurance in animal models — one study showed dramatic improvements in exercise capacity in aged mice
- Has anti-aging and cardioprotective properties related to mitochondrial health
What users report: MOTS-c is reported to produce a noticeable increase in physical energy and endurance — described by some as a “cleaner” feeling energy compared to stimulants. Improved gym performance, faster recovery between sessions, and a general sense of vitality are common reports. Effects on metabolic markers (blood glucose, insulin sensitivity) are less immediately perceptible but measurable over time.
Administration: Subcutaneous injection.
Typical dosing: 5–10 mg 2–3x per week.
Approximate pricing: $65–$100 per 10mg vial. Monthly cost approximately $130–$200 for typical dosing.
Putting the Stack Together
The Semax + Selank pairing is the natural foundation of this stack for most users — one providing cognitive activation and the other stress resilience. They complement each other well and have an excellent safety profile individually and in combination.
MOTS-c adds the physical energy and metabolic efficiency layer, making it particularly valuable for those who want performance benefits that carry into the gym as well as the office.
A common daily approach:
- Morning: Semax (100–300 mcg intranasal)
- As needed for stress/anxiety: Selank (250–500 mcg intranasal)
- 2–3x per week: MOTS-c (5–10 mg subcutaneous)
Estimated monthly cost:
- Semax + Selank only: $60–$120/month
- With MOTS-c added: $200–$320/month
Timeline Expectations
Semax and Selank effects are typically noticed acutely — within the same dosing session. Their full impact on mood stability and cognitive function tends to deepen over 2–4 weeks of regular use. MOTS-c energy effects are often reported within 1–2 weeks of consistent dosing.
Related Stacks
- Cognitive Function & Mood — Semax and Selank also feature prominently in the deeper cognitive and mood-focused stack
- Fat Loss & Metabolic Health — MOTS-c overlaps significantly with metabolic goals
- Sleep & Recovery — important context for any energy-focused protocol, since sleep quality is foundational
Health Disclaimer
BodyCircuit’s content is for informational and educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a licensed physician before beginning any peptide or wellness protocol. The regulatory status of peptides discussed in this series is evolving — some compounds are FDA-approved, some are expected to return to legal compounding status through physician prescription, and others remain restricted to research use only. BodyCircuit will update this series as regulatory guidance changes. Nothing in this series constitutes an endorsement, recommendation, or offer to sell any compound.
BodyCircuit